BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11465178)

  • 21. [Thymectomy in myasthenia gravis pseudoparalytica].
    Wolff H
    Zentralbl Chir; 1984; 109(21):1372-9. PubMed ID: 6524128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rethymectomy in patients with myasthenia gravis and recurrent thymoma].
    Pikin OV; Ryabov AB; Shcherbakova NI; Glushko VA; Kolbanov KI; Barmin VV; Aleksandrov OA; Bagrov VA; Khrushcheva NA; Salimov ZM; Martynova DE
    Khirurgiia (Mosk); 2021; (9):27-33. PubMed ID: 34480452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients.
    Jurado J; Javidfar J; Newmark A; Lavelle M; Bacchetta M; Gorenstein L; D'Ovidio F; Ginsburg ME; Sonett JR
    Ann Thorac Surg; 2012 Sep; 94(3):974-81; discussion 981-2. PubMed ID: 22748641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended thymectomy for myasthenia gravis patients: a 20-year review.
    Masaoka A; Yamakawa Y; Niwa H; Fukai I; Kondo S; Kobayashi M; Fujii Y; Monden Y
    Ann Thorac Surg; 1996 Sep; 62(3):853-9. PubMed ID: 8784019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trans-sternal thymectomy in myasthenia gravis].
    Inderbitzi R; Rösler K; Nachbur B
    Chirurg; 1991 Jun; 62(6):474-8. PubMed ID: 1914644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
    Huang CS; Hsu HS; Huang BS; Lee HC; Kao KP; Hsu WH; Huang MH
    Acta Neurol Scand; 2005 Aug; 112(2):108-14. PubMed ID: 16008537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis.
    López-Cano M; Ponseti-Bosch JM; Espin-Basany E; Sánchez-García JL; Armengol-Carrasco M
    Ann Thorac Surg; 2003 Nov; 76(5):1643-9; discussion 1649. PubMed ID: 14602301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited thymectomy for stage I or II thymomas.
    Onuki T; Ishikawa S; Iguchi K; Goto Y; Sakai M; Inagaki M; Yamamoto T; Onizuka M; Sato Y; Ohara K; Sakakibara Y
    Lung Cancer; 2010 Jun; 68(3):460-5. PubMed ID: 19717204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis.
    Zieliński M; Kuzdzal J; Szlubowski A; Soja J
    Ann Thorac Surg; 2004 Jul; 78(1):253-8. PubMed ID: 15223438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of early thymectomy in patients with myasthenia gravis.
    Bramis J; Pikoulis E; Leppäniemi A; Felekouras E; Alexiou D; Bastounis E
    Eur J Surg; 1997 Dec; 163(12):897-902. PubMed ID: 9449441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of surgical treatment for thymoma.
    Shamji F; Pearson FG; Todd TR; Ginsberg RJ; Ilves R; Cooper JD
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):43-7. PubMed ID: 6690858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis associated with thymoma: clinical characteristics and long-term outcome.
    Palmisani MT; Evoli A; Batocchi AP; Provenzano C; Tonali P
    Eur Neurol; 1994; 34(2):78-82. PubMed ID: 8174598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trans-sternal thymectomy. Surgical indications and perioperative management].
    Jonas J; Kaissling G; Druschky KF; Bähr R
    Zentralbl Chir; 2000; 125(8):671-7. PubMed ID: 10986748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors for the Exacerbation of Myasthenic Symptoms After Surgical Therapy for Myasthenia Gravis and Thymoma.
    Kato T; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Nakatochi M; Yokoi K
    Semin Thorac Cardiovasc Surg; 2020 Summer; 32(2):378-385. PubMed ID: 31518701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
    Xue L; Wang L; Dong J; Yuan Y; Fan H; Zhang Y; Wang Q; Ding J
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):692-697. PubMed ID: 29156018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients.
    Guillermo GR; Téllez-Zenteno JF; Weder-Cisneros N; Mimenza A; Estañol B; Remes-Troche JM; Cantu-Brito C
    Acta Neurol Scand; 2004 Mar; 109(3):217-21. PubMed ID: 14763961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral thoracoscopic extended thymectomy versus sternotomy.
    Fiorelli A; Mazzella A; Cascone R; Caronia FP; Arrigo E; Santini M
    Asian Cardiovasc Thorac Ann; 2016 Jul; 24(6):555-61. PubMed ID: 27206780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features, diagnostic approach, and therapeutic outcome in myasthenia gravis patients with thymectomy.
    Notash AY; Salimi J; Ramezanali F; Sheikhvatan M; Habibi G
    Acta Neurol Taiwan; 2009 Mar; 18(1):21-5. PubMed ID: 19537570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymectomy for myasthenia gravis.
    Mulder DG; Herrmann C; Keesey J; Edwards H
    Am J Surg; 1983 Jul; 146(1):61-6. PubMed ID: 6869680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymoma: prognostic factors.
    Etienne T; Deleaval PJ; Spiliopoulos A; Megevand R
    Eur J Cardiothorac Surg; 1993; 7(9):449-52. PubMed ID: 8217222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.